The Food and Drug Administration on Monday amended the emergency use authorization for the Pfizer-BioNTech coronavirus vaccine to expand eligibility for booster doses to individuals ages 12 to 15.
The post FDA Authorizes Pfizer COVID Booster for Kids Ages 12 to 15 appeared first on The Washington Informer.
